The consultant pharmacist and the physician in the nursing home: roles, relationships, and a recipe for success.

Nursing homes must provide sophisticated medical and personal care to a broad spectrum of residents and patients. Medications are an increasingly important part of that care. The risks and benefits of medications are widely published, but not necessarily recognized in the care of individual patients. Decisions about medications must be made in the proper context of the patient. Medications are often indicated for various illnesses, symptoms, and risk factors, but clinically significant adverse consequences of medications are common and typically mimic common syndromes. Timely recognition and management of adverse consequences requires vigilance and a high index of suspicion. Many factors influence medication prescribing and use in the nursing home. Newly updated OBRA surveyor guidance emphasizes the importance of following the full care process in implementing, dosing, monitoring, and adjusting medications. Physicians and consultant pharmacists have prominent, complementary roles in addressing medications in the nursing home. The purpose of this article is to clarify these roles, identify their basis (primarily, the care process), and discuss how physicians and consultant pharmacists can collaborate effectively to optimize medication use and minimize preventable adverse consequences.

[1]  T. Strandberg,et al.  Use of Inappropriate Medications and Their Prognostic Significance Among In-Hospital and Nursing Home Patients with and without Dementia in Finland , 2006, Drugs & aging.

[2]  Matthew H Samore,et al.  Risk Factors for Adverse Drug Events: A 10-Year Analysis , 2005, The Annals of pharmacotherapy.

[3]  J. Dimant Medication errors and adverse drug events in nursing homes: problems, causes, regulations, and proposed solutions. , 2002, Journal of the American Medical Directors Association.

[4]  Leigh F. Johnson,et al.  The time to act is now. , 2002 .

[5]  R. Kane,et al.  Nursing Home Residents Covered by Medicare Risk Contracts: Early Findings from the EverCare Evaluation Project , 2002, Journal of the American Geriatrics Society.

[6]  W. Schaffner,et al.  The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. , 1983, Journal of gerontology.

[7]  Julia K. Nguyen,et al.  Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. , 2006, The American journal of geriatric pharmacotherapy.

[8]  J. Avorn,et al.  Drug Use in the Nursing Home , 1996, Annals of Internal Medicine.

[9]  Albert Figueras,et al.  Adverse Drug Reactions in an Elderly Hospitalised Population , 2005, Drugs & aging.

[10]  P. Odegard,et al.  Interdisciplinary Care for Older Adults with Complex Needs: American Geriatrics Society Position Statement , 2006, Journal of the American Geriatrics Society.

[11]  J. Cornell,et al.  Adverse Events Related to Drugs and Drug Withdrawal in Nursing Home Residents , 1993, Journal of the American Geriatrics Society.

[12]  M. Llorente,et al.  Inappropriate Medication Prescribing in Homebound Older Adults , 1999, Journal of the American Geriatrics Society.

[13]  H. Martin,et al.  An opportunity for medication risk reduction, healthcare provider collaboration, and improved patient care: a retrospective analysis of osteoporosis management. , 2003, Journal of the American Medical Directors Association.

[14]  J. Hanlon,et al.  Incidence and predictors of all and preventable adverse drug reactions in frail elderly persons after hospital stay. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  H. Cohen,et al.  Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly. , 2004, The American journal of medicine.